As per the research conducted by GME, the Point of Care/ HIV Self-Test Marketwill grow with a CAGR value of 12.2 percent. The market will foresee a rise in its revenue size owing to a major driver i.e. increasing research and development activities to launch fourth generation technology based test kits which offers testing of IgG and IgM both simultaneously.
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Point of Care/ HIV Self-Test Market- Forecast to 2026"
Browse the Report @https://www.globalmarketestimates.com/market-report/global-point-of-care-or-hiv-self-test-market-3118
By Sample Type (Urine Sample & Blood Sample), By Technology (Second Generation Self-Test, Third Generation Self-Test, and Fourth Generation Self-Test), By Product Type (Self Sampling and Self-Testing), By End-User (Home Healthcare, Hospitals & Clinics, E-Commerce Channels and Diagnostic Laboratories), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis
Key Market Insights
·Human Immunodeficiency Virus or most popularly called as HIV is a virus that attacks healthy cells of the body which are responsible to maintain the immune system
·The market of clinical diagnostics has been seeing an increasing trend of using home based or at-home or self-test HIV kits to rule out the possible HIV infection cases at point of care level
·The 2nd generation technology will be the top segment in terms of revenue sales during the forecast period
·Atomo Diagnostics, Everlywell, autotest VIH, Biosure UK, SimplitudeByMe, Self Care Ltd., OraSure Technologies, Private iDNA, MyLAB Box, LetsGetChecked, Biosynex Group, bioLytical Laboratories Inc., Orange Life, Bedfordbiotech, Sedia Biosciences Corporation, and Chembio Diagnostic Systems are the players in the point of care/ HIV self-test market
Browse the Report @https://www.globalmarketestimates.com/market-report/global-point-of-care-or-hiv-self-test-market-3118
Sample Type Outlook (Revenue, USD Billion, 2021-2026)
·Blood
·Urine
Product Type Outlook (Revenue, USD Billion, 2021-2026)
·Self-Sampling
·Self-Testing
Technology Outlook (Revenue, USD Billion, 2021-2026)
·Second Generation Self-Test
·Third Generation Self-Test
·Fourth Generation Self-Test
End-User Outlook (Revenue, USD Billion, 2021-2026)
·Home Healthcare
·Hospitals & Clinics
·E-Commerce Channels
·Diagnostic Laboratories
Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of APAC
Central & South America
- Brazil
- Argentina
- Rest of CSA
Middle East & Africa
- Saudi Arabia
- UAE
- Rest of MEA
Contact: Tracy Simon
Email address: tracy.simon@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
0 Comments